Your browser doesn't support javascript.
loading
PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer.
Santos, María; Lanillos, Javier; Caleiras, Eduardo; Valdivia, Carlos; Roldan-Romero, Juan M; Laínez, Nuria; Puente, Javier; Beuselinck, Benoit; Oudard, Stéphane; Zucman-Rossi, Jessica; Navarro, Paloma; Robledo, Mercedes; Castellano, Daniel; de Velasco, Guillermo; García-Donas, Jesús; Rodriguez-Antona, Cristina.
Affiliation
  • Santos M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) Madrid 28029, Spain.
  • Lanillos J; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) Madrid 28029, Spain.
  • Caleiras E; Histopathology Core Unit, Spanish National Cancer Research Centre (CNIO) Madrid 28029, Spain.
  • Valdivia C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) Madrid 28029, Spain.
  • Roldan-Romero JM; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) Madrid 28029, Spain.
  • Laínez N; Department of Medical Oncology, Complejo Hospitalario de Navarra Pamplona, Spain.
  • Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC Madrid 28029, Spain.
  • Beuselinck B; Department of General Medical Oncology, Leuven Cancer Institute Leuven, Belgium.
  • Oudard S; Department of Medical Oncology, Hôpital Européen Georges Pompidou, AP-HP, University of Paris Paris, France.
  • Zucman-Rossi J; INSERM UMR1138 Centre de recherche des Cordeliers, University of Paris Paris, France.
  • Navarro P; Genitourinary and Gynecological Cancer Unit, HM Hospitales-Centro Integral Oncológico HM Clara Campal Madrid 28029, Spain.
  • Robledo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) Madrid 28029, Spain.
  • Castellano D; Centro de Investigación Biomédica en Red de Enfermedades Raras Valencia, Spain.
  • de Velasco G; Department of Medical Oncology, University Hospital 12 de Octubre Madrid 28029, Spain.
  • García-Donas J; Department of Medical Oncology, University Hospital 12 de Octubre Madrid 28029, Spain.
  • Rodriguez-Antona C; Genitourinary and Gynecological Cancer Unit, HM Hospitales-Centro Integral Oncológico HM Clara Campal Madrid 28029, Spain.
Am J Cancer Res ; 13(5): 2116-2125, 2023.
Article in En | MEDLINE | ID: mdl-37293154
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Cancer Res Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Cancer Res Year: 2023 Document type: Article Affiliation country: Country of publication: